Javygtor
Payments companies reported to CMS as associated with Javygtor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Javygtor, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Javygtor
These are the largest totals companies reported as associated with Javygtor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kathryn Eckert | Salt Lake City, UT | Medical Biochemical Genetics | $2,225.00 |
| Christine Horne | Chicago, IL | Pediatrics (Nurse Practitioner) | $560.00 |
| Erika Vucko | Chicago, IL | Nurse Practitioner | $162.11 |
| Hope Northrup | Houston, TX | Clinical Genetics (M.D.) | $149.65 |
| Neena Champaigne | Charleston, SC | Clinical Genetics (M.D.) | $113.76 |
| Kristen Lancaster | Charleston, SC | Clinical Genetics (M.D.) | $113.76 |
| Lauren Thompson | Charleston, SC | Medical Biochemical Genetics | $113.76 |
| Margaret Reilly | Charleston, SC | Internal Medicine | $105.11 |
| Holly Bernal | Palo Alto, CA | Nurse Practitioner | $100.33 |
| Stacie Leeper | Columbus, OH | Pediatrics (Nurse Practitioner) | $67.30 |
Prescribed Javygtor?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.